You are here: Home » News-CM » Companies » News
Business Standard

Strides Shasun signs definitive agreements with Vivimed Labs

Capital Market 

To form two joint venture companies

Strides Shasun has signed definitive agreements with to set up two joint venture companies, as under-

The 50:50 joint venture company in India will own the USFDA approved formulation facility in Alathur, Chennai and

The 50:50 joint venture company in Singapore through Strides Pharma Global, Singapore will own certain approved ANDAs and product pipeline.

The transaction is subject to customary closing conditions and expected to close by 31 May 2017.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Strides Shasun signs definitive agreements with Vivimed Labs

To form two joint venture companies

To form two joint venture companies

Strides Shasun has signed definitive agreements with to set up two joint venture companies, as under-

The 50:50 joint venture company in India will own the USFDA approved formulation facility in Alathur, Chennai and

The 50:50 joint venture company in Singapore through Strides Pharma Global, Singapore will own certain approved ANDAs and product pipeline.

The transaction is subject to customary closing conditions and expected to close by 31 May 2017.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Strides Shasun signs definitive agreements with Vivimed Labs

To form two joint venture companies

Strides Shasun has signed definitive agreements with to set up two joint venture companies, as under-

The 50:50 joint venture company in India will own the USFDA approved formulation facility in Alathur, Chennai and

The 50:50 joint venture company in Singapore through Strides Pharma Global, Singapore will own certain approved ANDAs and product pipeline.

The transaction is subject to customary closing conditions and expected to close by 31 May 2017.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22